AI Tools Drove $942 Million in Additional Healthcare Spending Over Two Years, Insurer Analysis Finds

Hospitals' use of artificial intelligence tools in the insurance claims process generated an additional $942 million in healthcare spending over a two-year period, according to an analysis published by the Blue Cross Blue Shield Association.

The BCBSA study identified "a sharp increase in patients being documented as having complex conditions," but concluded there is a "clear disconnect between coding and treatment," finding no evidence of corresponding change in care actually delivered to those patients.

The analysis points to AI-assisted medical coding software, which hospitals increasingly use when submitting claims, as a mechanism for documenting conditions in ways that justify higher reimbursements — without a documented shift in the underlying treatment provided.

The findings arrive as AI adoption on both sides of the hospital-insurer relationship accelerates, raising concerns among analysts and industry observers that the technology is compounding long-standing disputes over payments and treatments rather than resolving them.

Dr. Shiv Rao, founder of AI startup Abridge, acknowledged the risk in pointed terms, warning that AI deployment on both sides could lead to "a horrible dystopic future nobody wants to live in," with "bots fighting bots, agents fighting agents." Rao also said, however, that the technology might ultimately reduce tensions and cut costs if implemented differently.

Luke Chalker, senior vice president at the BCBSA, pushed back on the framing of the situation as a bilateral dispute. "It's not a war. It's a completely one-sided blood bath," Chalker said, characterizing insurers as the losing side.

The BCBSA analysis is the latest data point in a widening debate over whether AI in healthcare administration delivers efficiency gains or creates new vectors for cost inflation. Hospitals have their own financial incentives to document patient complexity accurately — a practice known as risk adjustment coding — and AI tools can systematize and scale that documentation in ways that manual processes cannot.

For insurers, the concern is that AI is accelerating the documentation of conditions that may not meaningfully affect the care a patient receives but do affect what the insurer must pay.

The tension reflects a broader pattern in enterprise AI adoption: tools deployed to improve workflow efficiency can also shift negotiating leverage between parties, sometimes in ways that aggregate into significant system-level costs. At $942 million over two years across the BCBSA's covered population, the figure is significant enough to draw regulatory and legislative attention, though no formal government inquiry has been announced.

Disclaimer